AKT1 and hepatocellular carcinoma: Upregulated FBXO32 promotes K48‐linked PHLPP2 polyubiquitination through K592 and K942 residues, inducing PHLPP2 degradation, activating PI3K–AKT signaling pathway, and consequently propelling malignant HCC progression.